Evidence method
Level · gp.fundamentals.capex_revenue_ratio
1.06% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
UTMD · Jun 30, 2024
UTAH MEDICAL PRODUCTS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001811884-24-000018General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
26.56% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-19.17% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
87.10% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
60.13% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
33.06% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.45% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
0.50% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History29 statesSelf-history eligible
Dec 31, 20217/9 normalizedLevel 3Mar 31, 20227/8 normalizedLevel 3Jun 30, 20227/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/9 normalizedLevel 3Dec 31, 20228/9 normalizedAmended as filedMar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/9 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/9 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/9 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 0.19%
- Current
- 1.06%
- Delta
- 0.86%
- Previous
- 46.53%
- Current
- 26.56%
- Delta
- -19.97%
- Previous
- -9.42%
- Current
- -19.17%
- Delta
- -9.74%
- Previous
- 81.48%
- Current
- 87.10%
- Delta
- 5.61%
- Previous
- 59.66%
- Current
- 60.13%
- Delta
- 0.46%
- Previous
- 34.24%
- Current
- 33.06%
- Delta
- -1.18%
- Previous
- 2.35%
- Current
- 2.45%
- Delta
- 0.11%
- Previous
- 0.70%
- Current
- 0.50%
- Delta
- -0.20%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · UTMD Fundamental State →Analogous To · UTMD state analogue 2 →Has State · UTAH MEDICAL PRODUCTS INC →Transitioned To · UTMD Fundamental State →Transitioned To · UTMD CAPEX_INTENSITY_INCREASED →Transitioned To · UTMD CASH_GENERATION_DECREASED →Transitioned To · UTMD GROWTH_DECREASED →Transitioned To · UTMD INVENTORY_PRESSURE_INCREASED →Transitioned To · UTMD MARGIN_INCREASED →Transitioned To · UTMD PROFITABILITY_DECREASED →Transitioned To · UTMD R_AND_D_INTENSITY_INCREASED →Transitioned To · UTMD SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.